tradingkey.logo
tradingkey.logo
Search

Inogen Inc

INGN
Add to Watchlist
6.300USD
-0.080-1.25%
Close 05/18, 16:00ETQuotes delayed by 15 min
170.57MMarket Cap
LossP/E TTM

More Details of Inogen Inc Company

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Inogen Inc Info

Ticker SymbolINGN
Company nameInogen Inc
IPO dateFeb 14, 2014
CEOSmith (Kevin R. M)
Number of employees766
Security typeOrdinary Share
Fiscal year-endFeb 14
Address859 Ward Drive
CityGOLETA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code93111
Phone18055620500
Websitehttps://www.inogen.com/
Ticker SymbolINGN
IPO dateFeb 14, 2014
CEOSmith (Kevin R. M)

Company Executives of Inogen Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
46.27K
-18.89%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
46.27K
-18.89%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
9.11K
-235.95%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Ryan Peterson
Mr. Ryan Peterson
Associate Director - Investor Relations
Associate Director - Investor Relations
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
46.27K
-18.89%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
46.27K
-18.89%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
9.11K
-235.95%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
U.S. revenue
209.84M
60.18%
Non-U.S. revenue
138.83M
39.82%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.70%
BlackRock Institutional Trust Company, N.A.
5.59%
Armistice Capital LLC
4.67%
Acadian Asset Management LLC
4.00%
Vanguard Capital Management, LLC
3.83%
Other
72.21%
Shareholders
Shareholders
Proportion
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.70%
BlackRock Institutional Trust Company, N.A.
5.59%
Armistice Capital LLC
4.67%
Acadian Asset Management LLC
4.00%
Vanguard Capital Management, LLC
3.83%
Other
72.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor
27.07%
Investment Advisor/Hedge Fund
24.09%
Hedge Fund
22.30%
Corporation
9.70%
Research Firm
2.60%
Individual Investor
2.19%
Family Office
0.81%
Bank and Trust
0.23%
Pension Fund
0.23%
Other
10.77%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
294
20.74M
75.89%
-3.29M
2025Q4
304
19.74M
72.70%
-4.65M
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.64%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
5.56%
+21.90K
+1.47%
Dec 31, 2025
Armistice Capital LLC
1.26M
4.64%
+400.00K
+46.30%
Dec 31, 2025
Acadian Asset Management LLC
1.08M
3.98%
+16.40K
+1.54%
Dec 31, 2025
Camber Capital Management LP
975.00K
3.58%
--
--
Jun 30, 2025
Columbia Threadneedle Investments (US)
860.55K
3.16%
+7.82K
+0.92%
Dec 31, 2025
Dafna Capital Management, LLC
827.07K
3.04%
+221.45K
+36.56%
Dec 31, 2025
Geode Capital Management, L.L.C.
599.41K
2.2%
-9.88K
-1.62%
Dec 31, 2025
Renaissance Technologies LLC
583.00K
2.14%
-8.40K
-1.42%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
View more
Cultivar ETF
Proportion0.59%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.55%
Federated Hermes MDT Small Cap Core ETF
Proportion0.25%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.11%
iShares Micro-Cap ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI